Adeno-associated virus as a gene delivery system

被引:53
|
作者
During, MJ
机构
[1] Department of Molecular Medicine, University of Auckland, School of Medicine, Auckland
关键词
adeno-associated virus; gene delivery; neurodegenerative disease;
D O I
10.1016/S0169-409X(97)00024-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adeno-associated virus (AAV) has several characteristics which make it extremely attractive as a gene transfer vector: (1) no known pathogenicity; (2) high efficiency and the ability to remain latent, (3) a minimal number of antigens ensuring minimal immunogenicity; (4) the ability to transduce post-mitotic cells; (5) possible advantages of site-specific integration; and (6) a broad host and cell range. The human isolate, AAV-2, is the best studied and has been the focus for gene delivery experiments. This review will discuss recent in vivo experiments demonstrating the utility of AAV in animal models of neurodegenerative disease. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:83 / 94
页数:12
相关论文
共 50 条
  • [31] Adeno-associated virus vector-mediated gene delivery to the vasculature and kidney
    Kapturczak, MH
    Chen, SF
    Agarwal, A
    [J]. ACTA BIOCHIMICA POLONICA, 2005, 52 (02) : 293 - 299
  • [32] Directed evolution of adeno-associated virus yields enhanced gene delivery vectors
    Narendra Maheshri
    James T Koerber
    Brian K Kaspar
    David V Schaffer
    [J]. Nature Biotechnology, 2006, 24 : 198 - 204
  • [33] Recombinant adeno-associated virus vector: Is it ideal for gene delivery in liver transplantation?
    Yang, ZF
    Wu, XB
    Tsui, TY
    Hou, YD
    Luk, JM
    Fan, ST
    [J]. LIVER TRANSPLANTATION, 2003, 9 (04) : 411 - 420
  • [34] Delivery of Adeno-Associated Virus Gene Therapy by Intravascular Limb Infusion Methods
    Gruntman, Alisha M.
    Flotte, Terence R.
    [J]. HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2015, 26 (03) : 159 - 164
  • [35] Novel Lung Tropic Adeno-Associated Virus Capsids for Therapeutic Gene Delivery
    Carneiro, Ana
    Lee, Hyuncheol
    Lin, Li
    van Haasteren, Joost
    Schaffer, David V.
    [J]. HUMAN GENE THERAPY, 2020, 31 (17-18) : 996 - 1009
  • [36] Changes in Adeno-Associated Virus-Mediated Gene Delivery in Retinal Degeneration
    Kolstad, Kathleen D.
    Dalkara, Deniz
    Guerin, Karen
    Visel, Meike
    Hoffmann, Natalie
    Schaffer, David V.
    Flannery, John G.
    [J]. HUMAN GENE THERAPY, 2010, 21 (05) : 571 - 578
  • [37] Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications
    Schoen, Christian
    Biel, Martin
    Michalakis, Stylianos
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 95 : 343 - 352
  • [38] In vivo gene delivery to articular chondrocytes mediated by an adeno-associated virus vector
    Ulrich-Vinther, M
    Duch, MR
    Soballe, K
    O'Keefe, RJ
    Schwarz, EM
    Pedersen, FS
    [J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 2004, 22 (04) : 726 - 734
  • [39] GENE TARGETING WITH ADENO-ASSOCIATED VIRUS VECTORS
    Russell, David W.
    [J]. JOURNAL OF GENE MEDICINE, 2011, 13 (7-8): : 415 - 415
  • [40] Adeno-associated virus serotypes for gene therapeutics
    Lisowski, Leszek
    Tay, Szun Szun
    Alexander, Ian Edward
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2015, 24 : 59 - 67